Which company manufactures the weight loss supplement endorsed by RFK Jr. and Donald Trump?
Executive summary
Available sources show RFK Jr. and former President Donald Trump have both been publicly involved in debates over weight‑loss treatments — notably GLP‑1 drugs such as Ozempic and Wegovy — but the search results do not identify a specific over‑the‑counter weight‑loss supplement that both men have "endorsed" nor name a company manufacturing such a supplement (available sources do not mention a single supplement manufacturer endorsed by both) [1] [2] [3].
1. What the reporting actually links RFK Jr. and Trump to: prescription GLP‑1 drugs, not one supplement company
News coverage in these search results emphasizes RFK Jr.’s and Trump’s public positions on prescription GLP‑1 weight‑loss medications — for example, Ozempic and Wegovy — and the politics around expanding access or restricting coverage, rather than promoting a commercially sold dietary supplement [1] [2] [3]. Several pieces describe RFK Jr. criticizing reliance on Ozempic and similar drugs and his stress on lifestyle approaches; others describe the Trump administration’s efforts to negotiate pricing for obesity medications [1] [2] [4] [3].
2. No source here ties both men to endorsing a single supplement product or manufacturer
The assembled search results include coverage of RFK Jr.’s broader stance favoring supplements and loosening FDA oversight (which supplement makers see as an opportunity) [5] [6]. They also document political theatre — photos, publicity events and the Oval Office announcement about drug pricing — but none of the items explicitly report that RFK Jr. and Trump jointly endorsed a named over‑the‑counter weight‑loss supplement or state the company that makes it (available sources do not mention such an endorsement or company) [7] [8] [9].
3. Why confusion between “supplements” and prescription drugs is common
Coverage highlights that RFK Jr. has expressed sympathy for dietary supplements and promised to reduce FDA “suppression” of vitamins and supplements, which industry players welcome [6] [5]. At the same time, political coverage centers on prescription GLP‑1 drugs and corporate deals with Eli Lilly and Novo Nordisk to lower costs — reporting that can blur public perception and fuel claims that politicians “endorse” specific commercial products when they are actually debating policy or negotiating with pharma companies [3] [4].
4. Competing perspectives in the sources
Some outlets emphasize RFK Jr.’s skepticism of GLP‑1 drugs and preference for lifestyle remedies, portraying him as a critic of pharmaceutical solutions [1] [2]. Other sources describe him moderating that stance in public contexts — for instance, praising a Trump deal on obesity drugs — suggesting political calculation or priorities that differ from his earlier rhetoric [4] [3]. Supplement‑industry pieces frame RFK Jr.’s approach as a boon for supplement makers, a potential conflict with public‑health advocates worried about lax regulation [5] [6].
5. What we can and cannot conclude from these reports
We can conclude from these sources that the public debate involves GLP‑1 prescription drugs, regulatory posture toward supplements, and policy moves by Trump and RFK Jr. that affect both sectors [1] [5] [3]. We cannot identify, from the provided reporting, a named over‑the‑counter weight‑loss supplement and manufacturer jointly endorsed by RFK Jr. and Donald Trump — the sources do not provide that information (available sources do not mention a manufacturer endorsed by both) [7] [8] [6].
6. How to verify the specific claim you asked about
To definitively answer “which company manufactures the weight loss supplement endorsed by RFK Jr. and Donald Trump,” review primary sources: direct public statements, social‑media posts, campaign materials, press releases, or reporting that quotes either man naming a product or company. None of the current search results include such a direct quote or product name; reporters instead focus on GLP‑1 drugs and broader supplement‑regulatory politics [1] [5] [3].
Limitations: this analysis uses only the supplied search results. If you have a specific tweet, post, or article that names a supplement, provide it and I will analyze the company and claims in that source (not found in current reporting) [7] [6].